Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paweł Knapp

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Folia Histochemica Et Cytobiologica|July 6, 2012
Pretreatment plasma levels and diagnostic utility of hematopoietic cytokines in cervical cancer or cervical intraepithelial neoplasia patientsSławomir Ławicki, Grażyna E Będkowska, Ewa Gacuta-Szumarska, et al.
Archives of Medical Science : AMS|January 25, 2021
Blood bioactive sphingolipids in patients with advanced serous epithelial ovarian cancer - mass spectrometry analysisPaweł Knapp, Lubomir Bodnar, Agnieszka Błachnio-Zabielska, et al.
Prostaglandins & Other Lipid Mediators|March 16, 2010
Altered sphingolipid metabolism in human endometrial cancerPaweł Knapp, Marcin Baranowski, Małgorzata Knapp, et al.
International Journal of Molecular Sciences|August 26, 2022
Energy Substrate Transporters in High-Grade Ovarian Cancer: Gene Expression and Clinical ImplicationsMarta Baczewska, Elżbieta Supruniuk, Klaudia Bojczuk, et al.
International Journal of Molecular Sciences|June 19, 2024
Diagnostic Utility of Selected Matrix Metalloproteinases (MMP-2, MMP-3, MMP-11, MMP-26), HE4, CA125 and ROMA Algorithm in Diagnosis of Ovarian CancerAleksandra Kicman, Ewa Gacuta, Monika Kulesza, et al.
Cancers|December 17, 2024
Diagnostic Utility of Metalloproteinases from Collagenase Group (MMP-1, MMP-8 and MMP-13) in Biochemical Diagnosis of Ovarian CarcinomaAleksandra Kicman, Ewa Gacuta, Rafał Marecki, et al.
Antioxidants (Basel, Switzerland)|February 24, 2024
Redox Biomarkers and Matrix Remodeling Molecules in Ovarian CancerElżbieta Supruniuk, Marta Baczewska, Ewa Żebrowska, et al.
Plos One|February 1, 2019
Current management of cervical cancer in Poland-Analysis of the questionnaire trial for the years 2002-2014 in relation to ASCO 2016 recommendationsTomasz Basta, Paweł Knapp, Paweł Blecharz, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|October 3, 2018
Studies on selected molecular factors in endometrial cancersAnna Markowska, Monika Szarszewska, Jakub Żurawski, et al.
Computers in Biology and Medicine|June 5, 2025
Repurposing of PI3K inhibitors for high-grade serous ovarian cancer: A novel competing endogenous network analysis-based approachAnna Erol, Karolina Chwialkowska, Anna Zeller, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Folia Histochemica Et Cytobiologica|July 6, 2012
Pretreatment plasma levels and diagnostic utility of hematopoietic cytokines in cervical cancer or cervical intraepithelial neoplasia patientsSławomir Ławicki, Grażyna E Będkowska, Ewa Gacuta-Szumarska, et al.
Archives of Medical Science : AMS|January 25, 2021
Blood bioactive sphingolipids in patients with advanced serous epithelial ovarian cancer - mass spectrometry analysisPaweł Knapp, Lubomir Bodnar, Agnieszka Błachnio-Zabielska, et al.
Prostaglandins & Other Lipid Mediators|March 16, 2010
Altered sphingolipid metabolism in human endometrial cancerPaweł Knapp, Marcin Baranowski, Małgorzata Knapp, et al.
International Journal of Molecular Sciences|August 26, 2022
Energy Substrate Transporters in High-Grade Ovarian Cancer: Gene Expression and Clinical ImplicationsMarta Baczewska, Elżbieta Supruniuk, Klaudia Bojczuk, et al.
International Journal of Molecular Sciences|June 19, 2024
Diagnostic Utility of Selected Matrix Metalloproteinases (MMP-2, MMP-3, MMP-11, MMP-26), HE4, CA125 and ROMA Algorithm in Diagnosis of Ovarian CancerAleksandra Kicman, Ewa Gacuta, Monika Kulesza, et al.
Cancers|December 17, 2024
Diagnostic Utility of Metalloproteinases from Collagenase Group (MMP-1, MMP-8 and MMP-13) in Biochemical Diagnosis of Ovarian CarcinomaAleksandra Kicman, Ewa Gacuta, Rafał Marecki, et al.
Antioxidants (Basel, Switzerland)|February 24, 2024
Redox Biomarkers and Matrix Remodeling Molecules in Ovarian CancerElżbieta Supruniuk, Marta Baczewska, Ewa Żebrowska, et al.
Plos One|February 1, 2019
Current management of cervical cancer in Poland-Analysis of the questionnaire trial for the years 2002-2014 in relation to ASCO 2016 recommendationsTomasz Basta, Paweł Knapp, Paweł Blecharz, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|October 3, 2018
Studies on selected molecular factors in endometrial cancersAnna Markowska, Monika Szarszewska, Jakub Żurawski, et al.
Computers in Biology and Medicine|June 5, 2025
Repurposing of PI3K inhibitors for high-grade serous ovarian cancer: A novel competing endogenous network analysis-based approachAnna Erol, Karolina Chwialkowska, Anna Zeller, et al.
Pageof 4